A semisynthetic broad spectrum antibiotic produced by chemical modification of the parent compound lincomycin. Clindamycin dissociates peptidyl-tRNA from the bacterial ribosome, thereby disrupting bacterial protein synthesis. (NCI04)
Clindamycin
Medicine
Pregnancy category:
Physiologic effect:
Marketed formulations:
- Clindamycin palmitate hydrochloride 15 solution
- Clindamycin phosphate 10 gel
- Clindamycin phosphate 10 foam aerosol
- Clindamycin phosphate 12 injectable solution
- Clindamycin phosphate 10 swab
- Clindamycin phosphate 10 lotion
- Clindamycin phosphate 10 solution
- Clindamycin hydrochloride 150 capsule
- Clindamycin phosphate 10 gel
- Clindamycin hydrochloride 300 gelatin coated capsule
Active moieties:
Active moiety of formulation:
- Clindamycin palmitate hydrochloride 15 solution
- Clindamycin phosphate 10 gel
- Clindamycin phosphate and benzoyl peroxide 10/25 gel
- Clindamycin phosphate and tretinoin 12/0.25 gel
- Clindamycin phosphate 10 foam aerosol
- Clindamycin phosphate 12 injectable solution
- Clindamycin phosphate 10 swab
- Clindamycin phosphate 10 lotion
- Clindamycin phosphate 10 solution
- Clindamycin hydrochloride 150 capsule
Active moiety of drug:
- Clindamycin
- Clindamycin palmitate hydrochloride
- Benzoyl peroxide/clindamycin
- Clindamycin/tretinoin
- Clindamycin hydrochloride
- Clindamycin phosphate
